Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Assays for BTK inhibitors

Assays for BTK inhibitors

US Patent 10012650 · Granted Jul 3, 2018

Estimated economic value: $73,356,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fused imidazopyridines as reversible inhibitors of Brutons Tyrosine Kinase (BTK)2025
Fused imidazopyridines as reversible inhibitors of Brutons Tyrosine Kinase (BTK)2025
Compounds and uses thereof2024
Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic dis2024
Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic dis2024
Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic dis2022
Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic dis2022
Heteroaryl compounds as BTK inhibitors and uses thereof2021
Heteroaryl compounds as BTK inhibitors and uses thereof2021
S1P modulating agents2021
Substituted bridged urea analogs as sirtuin modulators2020
Heteroaryl compounds as BTK inhibitors and uses thereof2019